null

SMILES: C[C@H]1C[C@H]2C[C@@H](C1)C[C@@H](C2)N1[C@H]2CC[C@@H]1C[C@@H](C2)n1c2ccccc2nc(N2CC[C@@H]2C(O)=O)c1=O

InChI Key: InChIKey=ZHAKSJXRYXIJIF-FWVOXTDISA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 220356   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human))	BDBM220356 (US9290488, A11a(i)) Show SMILES C[C@H]1C[C@H]2C[C@@H](C1)C[C@@H](C2)N1[C@H]2CC[C@@H]1C[C@@H](C2)n1c2ccccc2nc(N2CC[C@@H]2C(O)=O)c1=O |r,THB:8:10:16.17.15:12.13| Show InChI InChI=1S/C29H38N4O3/c1-17-10-18-12-19(11-17)14-22(13-18)32-20-6-7-21(32)16-23(15-20)33-25-5-3-2-4-24(25)30-27(28(33)34)31-9-8-26(31)29(35)36/h2-5,17-23,26H,6-16H2,1H3,(H,35,36)/t17-,18-,19+,20-,21+,22+,23+,26-/m1/s1	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	43	-10.0	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ...				US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM220356 (US9290488, A11a(i)) Show SMILES C[C@H]1C[C@H]2C[C@@H](C1)C[C@@H](C2)N1[C@H]2CC[C@@H]1C[C@@H](C2)n1c2ccccc2nc(N2CC[C@@H]2C(O)=O)c1=O |r,THB:8:10:16.17.15:12.13| Show InChI InChI=1S/C29H38N4O3/c1-17-10-18-12-19(11-17)14-22(13-18)32-20-6-7-21(32)16-23(15-20)33-25-5-3-2-4-24(25)30-27(28(33)34)31-9-8-26(31)29(35)36/h2-5,17-23,26H,6-16H2,1H3,(H,35,36)/t17-,18-,19+,20-,21+,22+,23+,26-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	323	-8.85	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece...				US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM220356 (US9290488, A11a(i)) Show SMILES C[C@H]1C[C@H]2C[C@@H](C1)C[C@@H](C2)N1[C@H]2CC[C@@H]1C[C@@H](C2)n1c2ccccc2nc(N2CC[C@@H]2C(O)=O)c1=O |r,THB:8:10:16.17.15:12.13| Show InChI InChI=1S/C29H38N4O3/c1-17-10-18-12-19(11-17)14-22(13-18)32-20-6-7-21(32)16-23(15-20)33-25-5-3-2-4-24(25)30-27(28(33)34)31-9-8-26(31)29(35)36/h2-5,17-23,26H,6-16H2,1H3,(H,35,36)/t17-,18-,19+,20-,21+,22+,23+,26-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	502	-8.59	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ...				US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW
					More data for this Ligand-Target Pair
Delta-type opioid receptor (Homo sapiens (Human))	BDBM220356 (US9290488, A11a(i)) Show SMILES C[C@H]1C[C@H]2C[C@@H](C1)C[C@@H](C2)N1[C@H]2CC[C@@H]1C[C@@H](C2)n1c2ccccc2nc(N2CC[C@@H]2C(O)=O)c1=O |r,THB:8:10:16.17.15:12.13| Show InChI InChI=1S/C29H38N4O3/c1-17-10-18-12-19(11-17)14-22(13-18)32-20-6-7-21(32)16-23(15-20)33-25-5-3-2-4-24(25)30-27(28(33)34)31-9-8-26(31)29(35)36/h2-5,17-23,26H,6-16H2,1H3,(H,35,36)/t17-,18-,19+,20-,21+,22+,23+,26-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3.05E+3	-7.52	n/a	n/a	n/a	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 μg membrane protein (recombinant delta opioid re...				US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW
					More data for this Ligand-Target Pair
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human))	BDBM220356 (US9290488, A11a(i)) Show SMILES C[C@H]1C[C@H]2C[C@@H](C1)C[C@@H](C2)N1[C@H]2CC[C@@H]1C[C@@H](C2)n1c2ccccc2nc(N2CC[C@@H]2C(O)=O)c1=O |r,THB:8:10:16.17.15:12.13| Show InChI InChI=1S/C29H38N4O3/c1-17-10-18-12-19(11-17)14-22(13-18)32-20-6-7-21(32)16-23(15-20)33-25-5-3-2-4-24(25)30-27(28(33)34)31-9-8-26(31)29(35)36/h2-5,17-23,26H,6-16H2,1H3,(H,35,36)/t17-,18-,19+,20-,21+,22+,23+,26-/m1/s1	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	139	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ...				US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM220356 (US9290488, A11a(i)) Show SMILES C[C@H]1C[C@H]2C[C@@H](C1)C[C@@H](C2)N1[C@H]2CC[C@@H]1C[C@@H](C2)n1c2ccccc2nc(N2CC[C@@H]2C(O)=O)c1=O |r,THB:8:10:16.17.15:12.13| Show InChI InChI=1S/C29H38N4O3/c1-17-10-18-12-19(11-17)14-22(13-18)32-20-6-7-21(32)16-23(15-20)33-25-5-3-2-4-24(25)30-27(28(33)34)31-9-8-26(31)29(35)36/h2-5,17-23,26H,6-16H2,1H3,(H,35,36)/t17-,18-,19+,20-,21+,22+,23+,26-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	357	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description [35S]GTPγS functional assays were conducted using freshly thawed membranes expressing human μ-receptors. Assay reactions were prepared by se...				US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW
					More data for this Ligand-Target Pair
Kappa-type opioid receptor (Homo sapiens (Human))	BDBM220356 (US9290488, A11a(i)) Show SMILES C[C@H]1C[C@H]2C[C@@H](C1)C[C@@H](C2)N1[C@H]2CC[C@@H]1C[C@@H](C2)n1c2ccccc2nc(N2CC[C@@H]2C(O)=O)c1=O |r,THB:8:10:16.17.15:12.13| Show InChI InChI=1S/C29H38N4O3/c1-17-10-18-12-19(11-17)14-22(13-18)32-20-6-7-21(32)16-23(15-20)33-25-5-3-2-4-24(25)30-27(28(33)34)31-9-8-26(31)29(35)36/h2-5,17-23,26H,6-16H2,1H3,(H,35,36)/t17-,18-,19+,20-,21+,22+,23+,26-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	>2.00E+4	n/a	n/a	7.4	25
Purdue Pharma L.P. US Patent					Assay Description Kappa opioid receptor membrane solution was prepared by sequentially adding final concentrations of 0.026 μg/μL kappa membrane protein (in-hous...				US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW
					More data for this Ligand-Target Pair